Furthermore, the inducible knockdown of claudin-5 in murine models results in severe neuroinflammation, increased mortality, and spontaneous recurrent seizures, highlighting the critical role of claudin-5 in maintaining BBB function and its potential as a therapeutic target in epilepsy [81]. This evidence concerns the gene CLDN5 and epilepsy.